Home / Posts Tagged "anti-cancer immunotherapy"

Sun Pharmaceutical Industries Ltd. announced on Monday that it has entered into a global licensing agreement with Swiss-Italian biotech firm Philogen to commercialize the specialty anti-cancer immunotherapy, Fibromun (L19TNF). This innovative treatment is currently under investigation in registration trials for the treatment of soft tissue

READ MORE
Best Shop Best Shop Best Shop Best Shop Best Shop Best Shop Best Shop